FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014052017> ?p ?o ?g. }

• W2014052017 endingPage "4962" @default.
• W2014052017 startingPage "4956" @default.
• W2014052017 abstract "Purpose To compare the efficacy of ovarian ablation versus chemotherapy in early breast cancer patients with hormone receptor–positive disease. Patients and Methods We conducted an open, randomized, multicenter trial including premenopausal breast cancer patients with hormone receptor–positive tumors and either axillary lymph node metastases or tumors with a size of 5 cm or more. Patients were randomly assigned to ovarian ablation by irradiation or to nine courses of chemotherapy with intravenous cyclophosphamide, methotrexate, and fluorouracil (CMF) administered every 3 weeks. Results Between 1990 and May 1998, 762 patients were randomly assigned, and the present analysis is based on 358 first events. After a median follow-up time of 8.5 years, the unadjusted hazard ratio for disease-free survival in the ovarian ablation group compared with the CMF group was 0.99 (95% CI, 0.81 to 1.22). After a median follow-up time of 10.5 years, overall survival (OS) was similar in the two groups, with a hazard ratio of 1.11 (95% CI, 0.88 to 1.42) for the ovarian ablation group compared with the CMF group. Conclusion In this study, ablation of ovarian function in premenopausal women with hormone receptor–positive breast cancer had a similar effect to CMF on disease-free and OS. No significant interactions were demonstrated between treatment modality and hormone receptor content, age, or any of the well-known prognostic factors." @default.
• W2014052017 created "2016-06-24" @default.
• W2014052017 creator A5027517833 @default.
• W2014052017 creator A5029098621 @default.
• W2014052017 creator A5034630560 @default.
• W2014052017 creator A5035353629 @default.
• W2014052017 creator A5044685097 @default.
• W2014052017 creator A5071541231 @default.
• W2014052017 creator A5071571360 @default.
• W2014052017 creator A5076487063 @default.
• W2014052017 creator A5077914640 @default.
• W2014052017 creator A5077936998 @default.
• W2014052017 creator A5090876784 @default.
• W2014052017 date "2006-11-01" @default.
• W2014052017 modified "2023-09-26" @default.
• W2014052017 title "Similar Efficacy for Ovarian Ablation Compared With Cyclophosphamide, Methotrexate, and Fluorouracil: From a Randomized Comparison of Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer" @default.
• W2014052017 cites W1262485082 @default.
• W2014052017 cites W1562190372 @default.
• W2014052017 cites W158884809 @default.
• W2014052017 cites W1835742705 @default.
• W2014052017 cites W1961026612 @default.
• W2014052017 cites W1971211622 @default.
• W2014052017 cites W2006521316 @default.
• W2014052017 cites W2007160568 @default.
• W2014052017 cites W2010871781 @default.
• W2014052017 cites W2012920290 @default.
• W2014052017 cites W2023548151 @default.
• W2014052017 cites W2045746241 @default.
• W2014052017 cites W206480088 @default.
• W2014052017 cites W2083907066 @default.
• W2014052017 cites W2095143568 @default.
• W2014052017 cites W2096471659 @default.
• W2014052017 cites W2123179063 @default.
• W2014052017 cites W2129686798 @default.
• W2014052017 cites W2167027232 @default.
• W2014052017 cites W2167725758 @default.
• W2014052017 cites W2338818079 @default.
• W2014052017 cites W2343407300 @default.
• W2014052017 cites W267005183 @default.
• W2014052017 doi "https://doi.org/10.1200/jco.2005.05.1235" @default.
• W2014052017 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17075113" @default.
• W2014052017 hasPublicationYear "2006" @default.
• W2014052017 type Work @default.
• W2014052017 sameAs 2014052017 @default.
• W2014052017 citedByCount "50" @default.
• W2014052017 countsByYear W20140520172012 @default.
• W2014052017 countsByYear W20140520172013 @default.
• W2014052017 countsByYear W20140520172014 @default.
• W2014052017 countsByYear W20140520172016 @default.
• W2014052017 countsByYear W20140520172017 @default.
• W2014052017 countsByYear W20140520172018 @default.
• W2014052017 countsByYear W20140520172019 @default.
• W2014052017 countsByYear W20140520172021 @default.
• W2014052017 countsByYear W20140520172022 @default.
• W2014052017 crossrefType "journal-article" @default.
• W2014052017 hasAuthorship W2014052017A5027517833 @default.
• W2014052017 hasAuthorship W2014052017A5029098621 @default.
• W2014052017 hasAuthorship W2014052017A5034630560 @default.
• W2014052017 hasAuthorship W2014052017A5035353629 @default.
• W2014052017 hasAuthorship W2014052017A5044685097 @default.
• W2014052017 hasAuthorship W2014052017A5071541231 @default.
• W2014052017 hasAuthorship W2014052017A5071571360 @default.
• W2014052017 hasAuthorship W2014052017A5076487063 @default.
• W2014052017 hasAuthorship W2014052017A5077914640 @default.
• W2014052017 hasAuthorship W2014052017A5077936998 @default.
• W2014052017 hasAuthorship W2014052017A5090876784 @default.
• W2014052017 hasBestOaLocation W20140520171 @default.
• W2014052017 hasConcept C121608353 @default.
• W2014052017 hasConcept C126322002 @default.
• W2014052017 hasConcept C143998085 @default.
• W2014052017 hasConcept C207103383 @default.
• W2014052017 hasConcept C23589133 @default.
• W2014052017 hasConcept C2776694085 @default.
• W2014052017 hasConcept C2776755627 @default.
• W2014052017 hasConcept C2780456651 @default.
• W2014052017 hasConcept C2781059491 @default.
• W2014052017 hasConcept C29456083 @default.
• W2014052017 hasConcept C44249647 @default.
• W2014052017 hasConcept C530470458 @default.
• W2014052017 hasConcept C71924100 @default.
• W2014052017 hasConcept C90924648 @default.
• W2014052017 hasConceptScore W2014052017C121608353 @default.
• W2014052017 hasConceptScore W2014052017C126322002 @default.
• W2014052017 hasConceptScore W2014052017C143998085 @default.
• W2014052017 hasConceptScore W2014052017C207103383 @default.
• W2014052017 hasConceptScore W2014052017C23589133 @default.
• W2014052017 hasConceptScore W2014052017C2776694085 @default.
• W2014052017 hasConceptScore W2014052017C2776755627 @default.
• W2014052017 hasConceptScore W2014052017C2780456651 @default.
• W2014052017 hasConceptScore W2014052017C2781059491 @default.
• W2014052017 hasConceptScore W2014052017C29456083 @default.
• W2014052017 hasConceptScore W2014052017C44249647 @default.
• W2014052017 hasConceptScore W2014052017C530470458 @default.
• W2014052017 hasConceptScore W2014052017C71924100 @default.
• W2014052017 hasConceptScore W2014052017C90924648 @default.
• W2014052017 hasIssue "31" @default.
• W2014052017 hasLocation W20140520171 @default.
• W2014052017 hasLocation W20140520172 @default.

• next